Suit filed against Uber and others after allegedly suffering a violent attack at the hands of a hailed driver in downtown ...

Sartorius Stedim Biotech has agreed to invest $3m in Nanotein Technologies, a US-based company engaged in the development of ...

Eight biotech CEOs wrote "An Open Letter to the Biopharmaceutical Industry" Sept. 3, in which they urged the industry and the federal government to hold themselves accountable during the race to ...

N/A = not available. As you can see, some biotech CEOs made off like Wall Street tycoons in 2014, although how they got paid and whether they deserved their pay are both up for debate.

Perhaps it’s just the summer slowdown, but it’s been a light month for executive hires in the pharma and biotech world.